IPIX .. post number 20142 *there* on my NSS SMB

New Post Public Reply Private Reply Replies (1) Message Board
4kids 4kids #54330
413
IPIX ..

post number 20142 *there* on my NSS SMB

hopefully post conveys here in total .. (formatting) .. if not it can be read there
apologies in advance re: formatting .. will try to fix during edit

note below what NR (non retail) has *reported* re: legal short on IPIX since last summer's *high* ..

https://investorshangout.com/post/view?id=523...z5j7NRlHel

NRs' go to comfort zone on this reporting while NR was actively working their cycles of money *against* IPIX ..
was 800,000 - 850,000

understand that the highest number reported by NR was 1.5M~ last July ..
specifically .. on 7.13.18 .. NR reported @ 1,529,297

as noted previously ..

Quote:
you can actually *see* why NR almost had no choice but to inject *volume* (liquidity) effective 9.12.18 into IPIX .. if the *highest* reporting was 1.5M and change last July .. months of NR sitting (reporting) @ 1.4M and change doesn't really help NR out


next *round* reported out of NR (to Finra) is AH's tomorrow ..
NR (non retail) has had some serious issues *reporting* factual daily volume avgs on IPIX (see below)

Settlement Date
Issue Name
Current Short
Previous Short
Chg
% Change from Prev
Avg Daily Vol
Days to Cover


https://otce.finra.org/otce/equityShortInterest
 
02/28/2019 Innovation Pharma 872,855 972,178 -99,323 -10.22 1,193,631 1
02/15/2019 Innovation Pharma 972,178 1,167,632 -195,454 -16.74 973,350 1
01/31/2019 Innovation Pharma 1,167,632 1,284,090 -116,458 -9.07 741,818 1.57
01/15/2019 Innovation Pharma 1,284,090 1,126,255 157,835 14.01 891,597 1.44

12/31/2018 Innovation Pharma 1,126,255 1,087,731 38,524 3.54 1,331,284 1
12/14/2018 Innovation Pharma 1,087,731 1,144,485 -56,754 -4.96 855,828 1.27
11/30/2018 Innovation Pharma 1,144,485 846,099 298,386 35.27 1,399,010 1
11/15/2018 Innovation Pharma 846,099 717,854 128,245 17.87 1,491,518 1
10/31/2018 Innovation Pharma 717,854 837,018 -119,164 -14.24 1,645,719 1
10/15/2018 Innovation Pharma 837,018 1,431,819 -594,801 -41.54 1,564,408 1
09/28/2018 Innovation Pharma 1,431,819 1,458,444 -26,625 -1.83 1,332,210 1.07
09/14/2018 Innovation Pharma 1,458,444 1,497,441 -38,997 -2.6 870,914 1.67
08/31/2018 Innovation Pharma 1,497,441 1,470,955 26,486 1.8 228,371 6.56
08/15/2018 Innovation Pharma 1,470,955 1,436,908 34,047 2.37 267,860 5.49
07/31/2018 Innovation Pharma 1,436,908 1,529,297 -92,389 -6.04 263,016 5.46
07/13/2018 Innovation Pharma 1,529,297 1,338,448 190,849 14.26 427,129 3.58


now realize this data is reported by those who self regulate .. with little to no oversight
and when actually caught .. a mere slap on the wrist fine is made up on other *targets* in minutes

which is why noting the volume avgs for the dates *reported* are so interesting .. because
as always when NR (non retail) is significantly UPSIDE DOWN on an OTC *target* like IPIX
volume matters

noting IPIX volume avgs (and PPS) every 2 weeks from 7.2.18 ~ 3.11.19


it's pretty clear why NR (non retail) took a sledgehammer .. they needed (and continue to need) actual Innovation Pharma investors to sell their IPIX *shares*

they failed .. reminder the easiest aspect NR (non retail) CON trolls is a targets' PPS ..
it's why it's so frequently noted by NR and their trading crews ..
illegally manipulating OTC targets is the sole province of NR .. it is never retail investors

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.5998Up 0.0098 (1.66 %) AS OF 3:59:15PM ET 07/02/2018


Volume 644,133
Volume (10 day Average) 362,826
Volume (90 day Average) 225,072


Market Capitalization $91.50M

====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.60Up 0.03 (5.26 %) AS OF 3:59:53PM ET 07/16/2018


Volume 277,411
Volume (10 day Average) 331,906
Volume (90 day Average) 221,234


====

Detailed Quote:IPIX hidden and closes IPIX down
INNOVATION PHARMACEUTICALS INC
0.518925Down -0.006075 (-1.16 %) AS OF 3:59:01PM ET 07/30/2018


Volume 128,655
Volume (10 day Average) 134,605
Volume (90 day Average) 211,671


====


Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.39Down -0.009 (-2.26 %) AS OF 3:58:01PM ET 08/13/2018


Volume 91,007
Volume (10 day Average) 143,246
Volume (90 day Average) 216,349


====

Detailed Quote:IPIX goes off hidden
INNOVATION PHARMACEUTICALS INC
0.39625Down -0.02375 (-5.65 %) AS OF 3:57:47PM ET 08/27/2018


Volume 111,105
Volume (10 day Average) 103,183
Volume (90 day Average) 204,551


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.435Down -0.13 (-23.01 %) AS OF 3:53:07PM ET 09/10/2018


Volume 139,753
Volume (10 day Average) 153,101
Volume (90 day Average) 194,770


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2955Down -0.0035 (-1.17 %) AS OF 3:59:26PM ET 09/24/2018


Volume 236,198
Volume (10 day Average) 671,612
Volume (90 day Average) 229,943


====
 
10/08/2018 0.24 0.2499 0.22 0.238 205,005

IPIX >> 10.8.18 EOD VOLUME

Volume 205,005
Volume (10 day Average) 483,260
Volume (90 day Average) 264,907


====

Detailed Quote:IPIX hidden
INNOVATION PHARMACEUTICALS INC
0.132Down -0.01419 (-9.71 %) AS OF 3:57:53PM ET 10/22/2018


Volume 951,411
Volume (10 day Average) 1,081,221
Volume (90 day Average) 371,375


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.185Down -0.002 (-1.07 %) AS OF 3:51:10PM ET 11/05/2018


Volume 1,033,642
Volume (10 day Average) 791,490
Volume (90 day Average) 436,190


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.11Down -0.012 (-9.84 %) AS OF 3:56:32PM ET 11/19/2018


Volume 1,058,420
Volume (10 day Average) 669,892
Volume (90 day Average) 471,252


====

Detailed Quote:IPIX .. hidden .. prior trade was as well
INNOVATION PHARMACEUTICALS INC
0.1343Down -0.0007 (-0.52 %) AS OF 3:56:14PM ET 12/03/2018


Volume 345,949
Volume (10 day Average) 700,470
Volume (90 day Average) 528,781


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.1293Down -0.0157 (-10.83 %) AS OF 3:54:37PM ET 12/17/2018


Volume 768,696
Volume (10 day Average) 435,575
Volume (90 day Average) 560,394


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.0955Down -0.0081 (-7.82 %) AS OF 3:57:25PM ET 12/31/2018 ***


Volume 628,843
Volume (10 day Average) 644,383
Volume (90 day Average) 612,395


*** interesting to note for the first time since NRs' volume injection beginning on 9.12.18
IPIX would have both 10 day and 90 day *volume algos* show within the same *% range*
12.31.18 was also the last time NR *reset* IPIX's 52 week low (7c)

====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.115Down -0.00175 (-1.50 %) AS OF 3:56:31PM ET 01/14/2019


Volume 540,838

Volume (10 day Average) 498,832
Volume (90 day Average) 651,734


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.11945Up 0.00095 (0.80 %) AS OF 3:51:02PM ET 01/28/2019


Volume 167,325
Volume (10 day Average) 298,709
Volume (90 day Average) 636,706


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.1439Down -0.0011 (-0.76 %) AS OF 3:56:00PM ET 02/11/2019


Volume 739,906
Volume (10 day Average) 580,296
Volume (90 day Average) 627,087


====

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.1237Down -0.0043 (-3.36 %) AS OF 3:58:20PM ET 02/25/2019


Volume 711,078
Volume (10 day Average) 392,784
Volume (90 day Average) 588,563


====

Detailed Quote:IPIX @ NITE's *ask* NC 5000
INNOVATION PHARMACEUTICALS INC
0.1279Up 0.0024 (1.91 %) AS OF 3:59:41PM ET 03/11/2019


Volume 359,435
Volume (10 day Average) 485,164
Volume (90 day Average) 547,518


Market Capitalization $22.54M

====================

currently as of this post .. with the reminder that it is far easier for NR (non retail) to *manipulate* the 10 day avg vs the 90 day avg ..

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.11Down -0.005 (-4.35 %) AS OF 12:25:08PM ET 03/25/2019


Volume 118,542
Volume (10 day Average) 303,117
Volume (90 day Average) 486,735


Market Capitalization $20.65M


so why would NR be so blatant in their lies to Finra about daily volume avg on IPIX ?

think about it ..

it's pretty clear IPIX should have triggered reg sho in 2018 and 2019
it also imo explains why DRS %s have been marked so *high* since 3.1.19
in *CONjunction* with IPIX's *volume* yet again cliff diving .. hmmm
 
Mar 22 NA NA NA 158,555 113,214 71.40%
Mar 21 NA NA NA 315,535 156,683 49.66%
Mar 20 NA NA NA 249,484 167,488 67.13%
Mar 19 NA NA NA 376,201 287,179 76.34%
Mar 18 NA NA NA 233,929 199,632 85.34%

Mar 15 NA NA NA 410,580 292,135 71.15%
Mar 14 NA NA NA 264,241 210,400 79.62%
Mar 13 NA NA NA 384,406 295,944 76.99%
Mar 12 NA NA NA 278,799 227,807 81.71%
Mar 11 NA NA NA 359,435 254,248 70.74%
Mar 08 NA NA NA 219,203 146,016 66.61%
Mar 07 NA NA NA 226,552 213,443 94.21%
Mar 06 NA NA NA 466,807 368,784 79.00%
Mar 05 NA NA NA 371,973 258,296 69.44%
Mar 04 NA NA NA 475,644 301,557 63.40%
Mar 01 NA NA NA 355,785 301,825 84.83%



link can be checked daily to see when reg sho is triggered on IPIX

https://otce.finra.org/otce/otcThreshold

usual camouflage by NR runs 5 to 10 days .. but it's the OTC ..
and NR has been UPSIDE DOWN on IPIX since last significant $money cycle hand off of late 2014 into 2015

4kids

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing Vishay's Versatile Control Knobs for Any Application

Updated Category News Views 181

Enhancing User Experience with Vishay's New Control Knobs Vishay Intertechnology, Inc. (NYSE: VSH) has recently introduced a groundbreaking series of control knobs tailored to enhance usability across various applications. These new knobs are designed for use with Vishay’s extensive panel potentiometer portfolio, ensuring smooth operation whether you're using bare hands...

Continue Reading
Exciting Keynote Speakers Set for 2025 ACTFL Conference

Updated Category News Views 276

Exciting Keynote Speakers for the Upcoming ACTFL Convention ACTFL is thrilled to announce the lineup of keynote speakers for the highly anticipated 2025 Annual Convention and World Languages Expo. Renowned actor Miguel Cervantes, celebrated for his role as Alexander Hamilton in Broadway's Hamilton, will deliver the Opening Keynote address. Joining him is Dr. Steve Boyes,...

Continue Reading
Join the Excitement at the OpenSSL Conference 2025 Today

Updated Category News Views 114

Early Bird Registration Now Available for the OpenSSL Conference Excitement is building as the inaugural OpenSSL Conference approaches, allowing individuals deeply interested in cryptography and secure systems to come together. While the event is set for three days, from October 7 to October 9, 2025, early registrations are currently open. Attendees can seize the...

Continue Reading
Sampo plc’s Strategic Share Buybacks: Impacts and Insights

Updated Category News Views 217

Sampo plc’s Recent Share Buybacks Overview Sampo plc recently made headlines with its strategic share buybacks, reflecting a robust commitment to its shareholders and a proactive approach in strengthening its stock performance. This move is part of a broader trend among companies looking to enhance shareholder value amidst fluctuating market conditions. The Buyback...

Continue Reading
Investigation into Soleno Therapeutics: Investors Urged to Act

Updated Category News Views 177

Overview of the Investigation There is a growing interest among investors regarding the activities of Soleno Therapeutics, Inc. (NASDAQ: SLNO). Recently, a prominent law firm has initiated an investigation on behalf of stockholders to determine if there have been any violations of federal securities laws or unethical business practices by the company. Background on Soleno...

Continue Reading